Cargando…

ELISPOT Refinement Using Spot Morphology for Assessing Host Responses to Tuberculosis

Tuberculosis is a global health problem. The Mycobacterium bovis Bacille Calmette Guerin (BCG) vaccine has variable efficacy (0-80%) so there is a drive to develop novel vaccines. The cytokine, interferon gamma (IFNγ), is an essential component of the protective response to M. tuberculosis (M. tb) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sibley, Laura S., White, Andrew D., Marriott, Alice, Dennis, Michael J., Williams, Ann, Marsh, Philip D., Sharpe, Sally A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972643/ https://www.ncbi.nlm.nih.gov/pubmed/24710359 http://dx.doi.org/10.3390/cells1010005

Ejemplares similares

Differences in monocyte: lymphocyte ratio and Tuberculosis disease progression in genetically distinct populations of macaques
por: Sibley, Laura, et al.
Publicado: (2019)

Longitudinal Assessment of an ELISPOT Test for Mycobacterium tuberculosis Infection
por: Hill, Philip C, et al.
Publicado: (2007)

Differences in host immune populations between rhesus macaques and cynomolgus macaque subspecies in relation to susceptibility to Mycobacterium tuberculosis infection
por: Sibley, Laura, et al.
Publicado: (2021)

Reversion of the ELISPOT test after treatment in Gambian tuberculosis cases
por: Aiken, Alexander M, et al.
Publicado: (2006)

Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays
por: Janetzki, Sylvia, et al.
Publicado: (2014)

Tuberculin skin test and ELISPOT/T. SPOT.TB in children and adolescents with juvenile idiopathic arthritis
por: Sztajnbok, Flavio, et al.
Publicado: (2014)

Using ELISPOT to Expose False Positive Skin Test Conversion in Tuberculosis Contacts
por: Hill, Philip C., et al.
Publicado: (2007)

Incidence of Tuberculosis and the Predictive Value of ELISPOT and Mantoux Tests in Gambian Case Contacts
por: Hill, Philip C., et al.
Publicado: (2008)

Evidence for a Role for Interleukin-17, Th17 Cells and Iron Homeostasis in Protective Immunity against Tuberculosis in Cynomolgus Macaques
por: Wareham, Alice S., et al.
Publicado: (2014)

Modified ELISPOT: Modifications of the Elispot Assay for T Cell Monitoring in Cancer Vaccine Trials
por: Malyguine, Anatoli
Publicado: (2005)

Log-Normal ELISPOT spot size distribution permits count harmonization among different laboratories
por: Sundararaman, Srividya, et al.
Publicado: (2014)

A novel strategy for interpreting the T-SPOT.TB test results read by an ELISPOT plate imager
por: Kim, Tae Yeul, et al.
Publicado: (2019)

Increased Level of IFN-γ and IL-4 Spot-Forming Cells on ELISPOT Assay as Biomarkers for Acute Graft-Versus-Host Disease and Concurrent Infections
por: Hirayama, Masahiro, et al.
Publicado: (2012)

Novel M. tuberculosis specific IL-2 ELISpot assay discriminates adult patients with active or latent tuberculosis
por: Della Bella, Chiara, et al.
Publicado: (2018)

An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques
por: Sharpe, S. A., et al.
Publicado: (2017)

Development of an in-house SARS-CoV-2 interferon-gamma ELISpot and plate reader-free spot detection method
por: Mak, Willem A., et al.
Publicado: (2022)

High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation
por: Sibley, Laura, et al.
Publicado: (2021)

Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol M. tuberculosis Challenge in Rhesus Macaques
por: White, Andrew D., et al.
Publicado: (2020)

Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus Macaques
por: Sarfas, Charlotte, et al.
Publicado: (2021)

Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis
por: Chiappini, Elena, et al.
Publicado: (2012)

Potential Role for IL-2 ELISpot in Differentiating Recent and Remote Infection in Tuberculosis Contact Tracing
por: Krummel, Benjamin, et al.
Publicado: (2010)

Response definition criteria for ELISPOT assays revisited
por: Moodie, Z., et al.
Publicado: (2010)

Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations
por: Sharpe, S., et al.
Publicado: (2016)

Reversion and conversion of Mycobacterium tuberculosis IFN-γ ELISpot results during anti-tuberculous treatment in HIV-infected children
por: Connell, Tom G, et al.
Publicado: (2010)

Identification of Major Factors Influencing ELISpot-Based Monitoring of Cellular Responses to Antigens from Mycobacterium tuberculosis
por: Smith, Steven G., et al.
Publicado: (2009)

Utility of interferon-γ ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa
por: Lawn, Stephen D, et al.
Publicado: (2007)

Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT
por: Maecker, Holden T, et al.
Publicado: (2005)

ELISPOT Cell Analysis Assay: Searching for Extracellular Footprints
por: Kalyuzhny, Alexander E.
Publicado: (2011)

Comparison of ELISpot and FluoroSpot in the Analysis of Swine Flu-Specific IgG and IgA Secretion by in Vivo Activated Human B Cells
por: Kesa, Gun, et al.
Publicado: (2012)

Distinguishing Latent from Active Mycobacterium tuberculosis Infection Using Elispot Assays: Looking Beyond Interferon-gamma
por: Tincati, Camilla, et al.
Publicado: (2012)

Dissecting the T Cell Response: Proliferation Assays vs. Cytokine Signatures by ELISPOT
por: Anthony, Donald D., et al.
Publicado: (2012)

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
por: White, A. D., et al.
Publicado: (2015)

Harmonization and qualification of an IFN-γ Enzyme-Linked ImmunoSpot assay (ELISPOT) to measure influenza-specific cell-mediated immunity within the FLUCOP consortium
por: Waerlop, Gwenn, et al.
Publicado: (2022)

High Reproducibility of ELISPOT Counts from Nine Different Laboratories
por: Sundararaman, Srividya, et al.
Publicado: (2015)

ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis
por: Ettischer‐Schmid, N., et al.
Publicado: (2020)

MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies
por: White, Andrew D., et al.
Publicado: (2021)

Equivalence of ELISpot Assays Demonstrated between Major HIV Network Laboratories
por: Gill, Dilbinder K., et al.
Publicado: (2010)

Defining ELISpot cut-offs from unreplicated test and control wells
por: Alexander, Neal, et al.
Publicado: (2013)

Role of ELISPOT Assays in Risk Assessment Pre- and Post-Kidney Transplantation
por: Zitzner, Jennifer R., et al.
Publicado: (2012)

How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?
por: Lima-Junior, Josué da Costa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9kj1ed16qj4jfsfo8kg4kdcgeh